Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JPH2 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | RP11-106M3.2 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | RP11-159D12.5 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | PIGT | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | LAMA5 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | RP11-321N4.5 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | SNRPD1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | EWSR1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | SH3BP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |